COVID-19 vaccine prior to infection may reduce long COVID symptoms

A new study investigates whether receiving two doses of a coronavirus vaccine before a SARS-CoV-2 infection is associated with reduced long COVID symptoms after 12 weeks. COVID-19 vaccines given prior to infection appear effective in resisting long COVID following breakthrough infections or infection after two doses. These findings have relevance for United Kingdom public health initiatives aimed at reducing the prevalence of long Covid in the U.K. population, especially in disadvantaged communities where prevalence is higher.